申请人:Magenta Therapeutics, Inc.
公开号:US20210139596A1
公开(公告)日:2021-05-13
Provided herein are modified antibodies, compounds used to make them, and intermediates in their synthesis; corn positions; formulations and methods, including methods of treating diseases, disorders or conditions, for example, cancer, in humans.